Product
mRNA-1273.815
3 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Phase 2/3 Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 VariantsStatus: Completed, Estimated PCD: 2023-11-17
Clinical trial
Randomized, Observer-Blind, Active-Controlled, Clinical Trial to Assess the Immunogenicity of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated AdultsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
An Open-Label, Phase 3 Study to Evaluate the Safety and Immunogenicity of mRNA Vaccines for SARS-CoV-2 Variants in Participants Aged 6 Months to < 6 YearsStatus: Recruiting, Estimated PCD: 2025-10-27